97 related articles for article (PubMed ID: 25478808)
1. Characterization of a new small bowel adenocarcinoma cell line and screening of anti-cancer drug against small bowel adenocarcinoma.
Suzuki H; Hirata Y; Suzuki N; Ihara S; Sakitani K; Kobayashi Y; Kinoshita H; Hayakawa Y; Yamada A; Watabe H; Tateishi K; Ikenoue T; Yamaji Y; Koike K
Am J Pathol; 2015 Feb; 185(2):550-62. PubMed ID: 25478808
[TBL] [Abstract][Full Text] [Related]
2. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
3. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
4. Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.
Zaaimi Y; Aparicio T; Laurent-Puig P; Taieb J; Zaanan A
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):154-60. PubMed ID: 26547136
[TBL] [Abstract][Full Text] [Related]
5. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.
Aparicio T; Svrcek M; Zaanan A; Beohou E; Laforest A; Afchain P; Mitry E; Taieb J; Di Fiore F; Gornet JM; Thirot-Bidault A; Sobhani I; Malka D; Lecomte T; Locher C; Bonnetain F; Laurent-Puig P
Br J Cancer; 2013 Dec; 109(12):3057-66. PubMed ID: 24196786
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
[TBL] [Abstract][Full Text] [Related]
7. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
8. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
10. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway.
Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X
PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502
[TBL] [Abstract][Full Text] [Related]
12. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
13. Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2).
Chung H; Chaudhry J; Lai JF; Young DJ; Carethers JM
Mutat Res; 2012 Jan; 729(1-2):73-80. PubMed ID: 22001236
[TBL] [Abstract][Full Text] [Related]
14. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
17. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway.
Adam L; San Lucas FA; Fowler R; Yu Y; Wu W; Liu Y; Wang H; Menter D; Tetzlaff MT; Ensor J; Manyam G; Arold ST; Huff C; Kopetz S; Scheet P; Overman MJ
Clin Cancer Res; 2019 Jan; 25(2):641-651. PubMed ID: 30352910
[TBL] [Abstract][Full Text] [Related]
18. Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
Hänninen UA; Katainen R; Tanskanen T; Plaketti RM; Laine R; Hamberg J; Ristimäki A; Pukkala E; Taipale M; Mecklin JP; Forsström LM; Pitkänen E; Palin K; Välimäki N; Mäkinen N; Aaltonen LA
PLoS Genet; 2018 Mar; 14(3):e1007200. PubMed ID: 29522538
[TBL] [Abstract][Full Text] [Related]
19. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]